Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 10, 2002, Pages 3137-3143

  Paulsen, Friedrich P ^a   Föge, Marc ^a   Thale, Andreas B ^a   Tillmann, Bernhard N ^a   Mentlein, Rolf ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; COMPARATIVE ANATOMY; CONJUNCTIVA; CORNEA; DRUG ABSORPTION; DRY EYE; FEMALE; HUMAN; LACRIMAL DUCT; LACRIMAL FLUID; LAMINA PROPRIA; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ABSORPTION; AGED; ANIMALS; AUTORADIOGRAPHY; EPITHELIUM; FEMALE; HUMANS; HYDROCORTISONE; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NASOLACRIMAL DUCT; TEARS; TRITIUM; VERTEBRATES;

EID: 0036784816     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Passo MS, Palmer EA, van Buskirk EM. Plasma timolol in glaucoma patients. Ophthalmology. 1984;91:1361-1363.
2. Tucker NA, Codere F. The effect of fluorescein volume on lacrimal outflow transit time. Ophthalmic Plast Reconstr Surg. 1994;10: 256-259.
3. Rohen JW. Haut und Sinnesorgane. In: von Möllendorf W, ed. Handbuch der Mikroskopischen Anatomie des Menschen. Vol. 3. Berlin: Springer; 1964:448-451.
4. Paulsen F, Thale A, Kohla G, et al. Functional anatomy of human lacrimal duct epithelium. Anat Embryol. 1998;198:1-12.
5. Thale A, Paulsen F, Kohla G, Schauer R, Rochels R, Tillmann B. Die ableitenden Tränenwege unter physiologischen und immunologischen Gesichtspunkten. Ophthalmologe. 2001;98:56-63.
6. Paulsen FP, Thale AB, Hallmann UJ, Schaudig U, Tillmann BN. The cavernous body of the human efferent tear ducts: function in tear outflow mechanism. Invest Ophthalmol Vis Sci. 2000;41:965-970.
7. Paulsen F, Hallmann U, Paulsen J, Thale A. Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat. 2000;197:373-381.
8. Maltzman BA, Favetta JR. Dacryolithiasis. Ann Ophthalmol. 1979; 11:473-475.
9. Yazici B, Hammad AM, Meyer DR. Lacrimal sac dacryoliths: predictive factors and clinical characteristics. Ophthalmology. 2001; 108:1308-1312.
10. Paulsen F, Thale A, Mentlein R. What happens to tears inside the efferent lacrimal passage?-an animal experimental study. Graefes Arch Clin Exp Ophthalmol. 2000;238:496-499.
11. Gebert G. Modes of absorption. In: Gardner MLG, Steffens K-H, eds. Absorption of Orally Administered Enzymes. New York: Springer; 1995:23-28.
12. Moore CP, Wilsman NJ, Nordheim EV, Majors LJ, Collier LL. Density and distribution of canine conjunctival goblet cells. Invest Ophthalmol Vis Sci. 1987;28:1925-1932.
13. May CA, Fuchs AV, Scheib M, Lütien-Drecoll E. Characterization of nitrergic neurons in the porcine and human ciliary nerves. Invest Ophthalmol Vis Sci. 2002;43:581-586.
14. Gormezano I, Schneiderman N, Deaux E, Fuentes I. Nictitating membrane: classical conditioning and extinction in the albino rabbit. Science. 1962;138:33-34.
15. Tarjan E, Denton DA, McKinley MJ, Nelson JF, Weisinger RS. What makes wild rabbits drink? J Physiol (Paris). 1984;79:466-470.
16. Denton DA, Nelson JF, Tarjan E. Water and salt intake of wild rabbits (Oryctolagus cuniculus (L)) following dipsogenic stimuli. J Physiol. 1985;326:285-301.
17. Maurice DM. The effect of the low blink rate in rabbits on topical drug penetration. J Ocul Pharmacol Ther. 1995;11:279-304.
18. Maurice DM. Influence on corneal permeability of bathing with solutions of differing reaction on tonicity. Br J Ophthalmol. 1955; 39:463-473.
19. Maurice DM. The use of fluorescein in ophthalmological research. Invest Ophthalmol Vis Sci. 1967;6:464-477.
20. Maurice DM. The dynamics and drainage of tears. Int Ophthalmol Clin. 1973;13:103-116.
21. Macdonald EA, Maurice DM. Loss of fluorescein across the conjunctiva. Exp Eye Res. 1991;53:427-430.
22. Paulsen FP, Hinz M, Schaudig U, Thale AB, Hoffmann W. TFF-peptides in the human efferent tear ducts. Invest Ophthalmol Vis Sci. In press.
23. Paulsen FP, Pufe T, Schaudig U, et al. Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci. 2001;42:2157-2163.
24. Paulsen F, Pufe T, Schaudig U, et al. Protection of human efferent tear ducts by antimicrobial peptides. In: Sullivan DA, ed. Lacrimal Gland, Tear Film and Dry Eye Syndromes. Vol. 3. New York: Kluwer Academic, Plenum Publishers. In press
25. Paulsen F, Paulsen J, Thale A, Tillmann B. Mucosa-associated lymphoid tissue (MALT) in the human efferent tear ducts. Virchows Arch. 2000;437:185-189.
26. Paulsen F, Paulsen J, Thale A, Schaudig U, Tillmann B. Organized mucosa associated lymphoid tissue in human nasolacrimal ducts. In: Sullivan DA, ed. Lacrimal Gland, Tear Film and Dry Eye Syndromes. Vol. 3. New York: Kluwer Academic, Plenum Publishers. In press.
27. Sirigu P, Maxia C, Puxeddu R, Zucca I, Piras F, Perra MT. The presence of a local immune system in the upper blind and lower part of the human nasolacrimal duct. Arch Histol Cytol. 2000;63: 431-439.
28. Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci. 2001;42:566-574.